오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ivabradine hydrochloride, quantity: 5.39 mg (equivalent: ivabradine, qty 5 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; colloidal anhydrous silica; maltodextrin; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000 - treatment of chronic stable angina symptomatic treatment of chronic stable angina due to atherosclerotic coronary artery disease in patients with normal sinus rhythm and heart rate at or above 70 bpm, who are unable to tolerate or have a contraindication to the use of beta-blockers, or in combination with atenolol 50mg once daily when angina is inadequately controlled.,treatment of chronic heart failure treatment of symptomatic chronic heart failure of nyha classes ii or iii and with documented left ventricular ejection fraction (lvef) ? 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ivabradine hydrochloride, quantity: 8.085 mg (equivalent: ivabradine, qty 7.5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; colloidal anhydrous silica; lactose monohydrate; maltodextrin; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000 - treatment of chronic stable angina symptomatic treatment of chronic stable angina due to atherosclerotic coronary artery disease in patients with normal sinus rhythm and heart rate at or above 70 bpm, who are unable to tolerate or have a contraindication to the use of beta-blockers, or in combination with atenolol 50mg once daily when angina is inadequately controlled.,treatment of chronic heart failure treatment of symptomatic chronic heart failure of nyha classes ii or iii and with documented left ventricular ejection fraction (lvef) ? 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - ivabradine - film-coated tablet - 5 milligram(s) - ivabradine

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - ivabradine - film-coated tablet - 7.5 milligram(s) - ivabradine

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

med-el implant systems australasia pty ltd - 35643 - stimulator, electrical, auditory, cochlea - the mi1200 pin implant is the implantable part of the med-el cochlear implant system and can only be used together with compatible med-el external components. the device consists of a stimulator, a coil with a removable magnet within its center, a reference electrode, an eap reference electrode and an active electrode permanently attached to the stimulator. also included in this system is an implant template that replicates the outline of the corresponding implant. the med-el cochlear implant system is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition. additionally the med-el cochlear implant system used in combination with the implant variant synchrony pin +flex24 is intended to evoke auditory sensations via electrical stimulation or via combined electric-acoustic stimulation (eas) of the auditory pathways for partially deaf in

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

med-el implant systems australasia pty ltd - 35643 - stimulator, electrical, auditory, cochlea - the mi1200 implant is the implantable part of the med-el cochlear implant system and can only be used together with compatible med-el external components. the device consists of a stimulator, a coil with a removable magnet within its center, a reference electrode, an eap reference electrode and an active electrode permanently attached to the stimulator. also included in this system is an implant template that replicates the outline of the corresponding implant. the med-el cochlear implant system is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition. additionally the med-el cochlear implant system used in combination with the implant variant synchrony +flex24 is intended to evoke auditory sensations via electrical stimulation or via combined electric-acoustic stimulation (eas) of the auditory pathways for partially deaf individual

싱가포르 - 영어 - HSA (Health Sciences Authority)

medel pte. ltd. - ear, nose & throat - the synchrony abi is used for electrical stimulation of the cochlear nucleus (cn) via an implanted stimulator and a specially designed electrode array to evoke auditory sensations in patients with non-functional cochlear nerves.

싱가포르 - 영어 - HSA (Health Sciences Authority)

medel pte. ltd. - ear, nose & throat - the cochlear implant mi1200 synchrony is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition. additional the med-el cochlear implant system used in combination with the implant variant syndhrony flex24 and +flex20 is intended to evoke auditory sensations via electrical stimulation or via combined electric-acoustic stimulation (eas) of the auditory pathways for partially deaf individuals, who obtain benefit from acoustic amplification in the lower frequencies only.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

med-el implant systems australasia pty ltd - 35643 - stimulator, electrical, auditory, cochlea - the mi1250 pin is the implantable part of the med-el hearing implant system and consists of a stimulator, a coil with a removable magnet within its centre, a reference electrode, an eap reference electrode and an active electrode permanently attached to the stimulator. it features titanium fixation pins to secure the placement of the implant for stability. the corresponding implant template is provided with the mi1250 pin. the med-el cochlear implant system is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition. additionally the med-el cochlear implant system used in combination with the implant variant synchrony 2 pin flex24 is intended to evoke auditory sensations via electrical stimulation or via combined electric-acoustic stimulation (eas) of the auditory pathways for partially deaf individuals, who obtain benefit from acousti

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

med-el implant systems australasia pty ltd - 35643 - stimulator, electrical, auditory, cochlea - the mi1250 implant is the implantable part of the med-el hearing implant system and can only be used together with compatible med-el external components. the device consists of a stimulator, a coil with a removable magnet within its center, a reference electrode, an eap reference electrode and an active electrode permanently attached to the stimulator. also included in this system is an implant template that replicates the outline of the corresponding implant. the med-el cochlear implant system is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition. additionally the med-el cochlear implant system used in combination with the implant variant synchrony 2 flex24 is intended to evoke auditory sensations via electrical stimulation or via combined electric-acoustic stimulation (eas) of the auditory pathways for partially deaf individual